RESUMEN
BACKGROUND: Cigarette smoking has a considerable health and economic burden in modern society, with increased risk of morbidity and mortality. Therefore, smoking cessation policies and medical treatments are essential. However, cessation rates are low and the abandonment of the consultation is common. The identification of characteristics that may predict adherence will help defining the best treatment strategy. This study aimed to identify predictors of follow-up loss in smoking cessation consultation. METHODS: We made a retrospective observational study, including a cohort of patients who started smoking cessation consultation (April-December 2018). Clinical data from consultations was collected and analyzed with IBM SPSS Statistics (SPSS, RRID:SCR_002865). RESULTS: A total of 175 patients was selected (41.1% female), with a mean age of 53±12 years. Eighty-five patients (48.6%) were discharged for abandonment. They had a median pack-year unit 38±36 (P=0.011), Fagerström and Richmond scores of 5±2 and 7±2, respectively. There was an association between women (P<0.001), younger age (P<0.001), depression/anxiety (P=0.023), lower smoking load (P=0.019), starting the treatment in the first appointment (P=0.004) and the abandonment of the consultation. In binary logistic regression, younger age (less than 50 years) (OR =4.39; 95% CI: 1.99-9.70), starting the treatment in the first appointment (OR =3.04; 95% CI: 1.44-6.42) and depression/anxiety (OR =2.30; 95% CI: 1.08-4.88) remained independent predictors of loss in follow-up. CONCLUSIONS: Women, younger age, depression/anxiety, lower smoking load and starting treatment in the first appointment are predictors of follow-up loss, so, these patients may benefit from more frequent evaluations and intensive cognitive approach. This study also raises awareness about the adequate timing to start pharmacological support for smoking cessation.
RESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Anciano , Absceso Pulmonar/diagnóstico por imagen , Absceso Pulmonar/tratamiento farmacológico , Broncoscopía/métodos , Fístula Bronquial/diagnóstico por imagen , Fístula del Sistema Respiratorio/diagnóstico por imagen , Fístula del Sistema Respiratorio/tratamiento farmacológico , Pulmón/diagnóstico por imagen , Pulmón/patología , Antibacterianos/uso terapéutico , Hemoptisis/complicaciones , Hemoptisis/tratamiento farmacológicoRESUMEN
No disponible
Asunto(s)
Humanos , Femenino , Anciano , Secuestro Broncopulmonar/complicaciones , Secuestro Broncopulmonar/diagnóstico por imagen , Isquemia Miocárdica/etiología , Secuestro Broncopulmonar/fisiopatología , Electrocardiografía , Dolor en el Pecho/diagnóstico por imagen , Dolor en el Pecho/etiología , Angiografía , Diagnóstico DiferencialRESUMEN
Breast tuberculosis (TB) is considered an uncommon disease with an estimated incidence of 0.1% of all breast lesions reported in developed countries. A 53-year-old Caucasian woman, with a medical history of Crohn's disease, previously treated with infliximab for 3 months suspended due to a presumptive diagnosis of TB for which antitubercular regimen was started. Five months after, a painful lump in the left breast was identified by the patient. Mammary ultrasound confirmed left breast nodules and axillary adenopathies. Histology and microbiology of both lesions confirmed breast TB. Molecular drug susceptibility testing in both samples revealed no resistance to first line anti-TB drugs and the regimen was maintained for 1 year, with clinical and radiological improvement. Mammary gland involvement usually results from lymphatic extension and differential diagnosis frequently includes breast cancer or bacterial abscess.